The USPSTF recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70.
Patients with pyelonephritis
Aymptomatic people with BMI > 25 kg/m2 (23 kg/m2 if Asian-American)
Age > 45
Children or adolescents with BMI > 85th centile or with additional risk factors
High-risk racial-ethnic background
First-degree relative with T2DM
History of GDM
PCOS
TGs > 250 ml/dL or HDL cholesterol < 35 mg/dL
History of CVD
Inactivity, severe obesity (BMI > 35 kg/m2), acanthosis nigricans
IGT, IFG or prediabetes: restest annualy
BMI = body mass index; CVD = cardiovascular disease; GDM = gestational diabetes; HDL = high-density lipoprotein; IGT = impaired glucose tolerance; IFG = impaired fasting glucose; PCOS = polycystic ovary syndrome; TG = triglycerides; T2DM = type 2 diabetes mellitus
The US Preventive Services Task Force recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70. Individuals with a history of PCOS< GDM, and those of higher-risk racial and ethnic groups should be considered for screening at younger ages and lower body mass indexes.
Read more: Type 2 diabetes in the non-pregnant patient